ClinicalTrials.Veeva

Menu

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease

The Ohio State University logo

The Ohio State University

Status

Completed

Conditions

Allogeneic Stem Cell Transplant
Acute Graft-versus-Host Disease

Treatments

Procedure: Blood samples

Study type

Observational

Funder types

Other

Identifiers

NCT01521039
OSU-11002

Details and patient eligibility

About

Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (GVHD).

Full description

The purpose of this study is to examine whether the expression levels of a novel class of molecules, called microRNAs, are associated with acute graft-versus-host disease frequency and severity. Acute graft-versus-host disease is a Acute GVHD is a medical condition that can become very serious. It happens when the donor cells attack and damage your tissues after transplant.

Enrollment

259 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Patients who are receiving allogeneic stem cell transplantation at the Ohio State University Blood and Marrow Transplantation program are eligible and will be consented for the study.

Trial design

259 participants in 1 patient group

Allogeneic SCT recipients
Description:
Patients who are receiving allogeneic stem cell transplantation at the Ohio State University are eligible and will be consented for the study.
Treatment:
Procedure: Blood samples

Trial contacts and locations

1

Loading...

Central trial contact

Hannah Choe, MD; Ohio State University Comprehensive Cancer Center

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems